Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Department of Orthopaedic Surgery, University of Utah, Salt Lake City, Utah, USA.
Acta Haematol. 2021;144(4):458-464. doi: 10.1159/000511953. Epub 2021 Jan 7.
Normal human bone marrow cells are critical for studies of hematopoiesis and as controls to assess toxicity. As cells from commercial vendors are expensive, many laboratories resort to cancer-free bone marrow specimens obtained during staging or to umbilical cord blood cells, which may be abnormal or reflect a much younger age group compared to the disease samples under study. We piloted the use of femoral heads as an alternative and inexpensive source of normal bone marrow. Femoral heads were obtained from 21 successive patients undergoing elective hip arthroplasty. Mononuclear cells (MNCs) were purified with Ficoll, and CD3+, CD14+, and CD34+ cells were purified with antibody-coated microbeads. The median yield of MNCs was 8.95 × 107 (range, 1.62 × 105-2.52 × 108), and the median yield of CD34+ cells was 1.40 × 106 (range, 3.60 × 105-9.90 × 106). Results of downstream applications including qRT-PCR, colony-forming assays, and ex vivo proliferation analysis were of high quality and comparable to those obtained with standard bone marrow aspirates. We conclude that femoral heads currently discarded as medical waste are a cost-efficient source of bone marrow cells for research use.
正常人骨髓细胞对于造血研究和作为评估毒性的对照至关重要。由于商业供应商的细胞昂贵,许多实验室使用来自癌症患者的骨髓标本,这些标本是在分期时获得的,或者使用脐带血,这些细胞可能异常,或者与正在研究的疾病样本相比反映了更年轻的年龄组。我们尝试使用股骨头作为替代和廉价的正常骨髓来源。从 21 名接受择期髋关节置换术的连续患者中获得股骨头。使用 Ficoll 纯化单核细胞(MNC),并用抗体包被的微珠纯化 CD3+、CD14+和 CD34+细胞。MNC 的中位数产量为 8.95×107(范围,1.62×105-2.52×108),CD34+细胞的中位数产量为 1.40×106(范围,3.60×105-9.90×106)。下游应用的结果,包括 qRT-PCR、集落形成测定和体外增殖分析,质量都很高,与使用标准骨髓抽吸物获得的结果相当。我们得出结论,目前作为医疗废物丢弃的股骨头是研究用骨髓细胞的一种具有成本效益的来源。